1. Purdue joining pharma’s top settlement list alongside Merck, GSK, and Pfizer — Biosimilars running into more roadblocks in the US — Big Pharma companies pay for exclusive access to UK genetic data — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Praluent...it's over.

Discussion in 'Regeneron' started by anonymous, Feb 27, 2019 at 8:17 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

  2. anonymous

    anonymous Guest

  3. anonymous

    anonymous Guest

    We shall see Amgen troll. You got your ass kicked last time in court. Supreme Court told you to go pound sand . BTW very strong data with Fourier - LOL
     
  4. anonymous

    anonymous Guest

    umm have you looked at market share? Soon we will be 70-30, talk about getting your ass kicked give us a break
     
  5. anonymous

    anonymous Guest

    CV team:

    I know a lot of you well. I cannot say very much without giving myself away. Not sure how many of the big guys even read or care about CP. Im convinced now that they don't really care about you at all. I love you guys and women so much. I know how difficult this has been and how hard you have worked. I just want to give people a heads up. I don't like what I've learned.

    Please be smart. Polish up the resume. Change is coming. Soon. Litigation looking bad. We've only been given one side of the story. I hope our team is still here in 18 months. Probably not.

    BE PROACTIVELY LOOKING ELSEWHERE!!!!
     
  6. anonymous

    anonymous Guest

    Amgen troll at work again. Don't think there's a more paranoid run to the hills group than Regeneron. Reps spend most their day texting and jawing on the phone with each other.
     
  7. anonymous

    anonymous Guest

    yeah something didnt sound right on the national call
     
  8. anonymous

    anonymous Guest

    Recall is coming new safety event for the class is just starting to break
     
  9. anonymous

    anonymous Guest

    Bullshit
     
  10. anonymous

    anonymous Guest

    You strike me as very bright, you must be in sales leadership yes?
     
  11. anonymous

    anonymous Guest

    Word is company is walking away
     
  12. anonymous

    anonymous Guest

    Walking away from what?
    If it’s a safety issue that is nonsense.
    If it is from the cost of marketing this money losing dog with Sanofi, yes.
     
  13. anonymous

    anonymous Guest

    Comical all the talk on this string. Company is waiting forn4/28. That will tell us what the market will be. Until then do your fucking job.
     
  14. anonymous

    anonymous Guest

    You idiots are ALL trolls talking shit about one another. Your all a bunch of shitbags who cut each other’s nut sacks every chance you get. You deserve to lose your asses and try to survive working a REAL Job !
     
  15. anonymous

    anonymous Guest

    4/28? If you are wondering if there will be any market moving changes you are really Naive or a complete idiot.
     
  16. anonymous

    anonymous Guest

    Not only is it the beginning of the end-or worse-because of the litigation, but Paige White is the absolute killer. Sickening to hear her approach and ideas.

    Please-can we find a decent NSD? Someone who actually knows and understands the business? This lady will destroy us
     
  17. anonymous

    anonymous Guest

    This is a reflection on Lens ability in hiring. All fingers should be pointed at him.
     
  18. anonymous

    anonymous Guest

    Might be right
     
  19. anonymous

    anonymous Guest

    Yall ain’t cutting it with Praluent promotion. Praluent will go down like nippsy hustle and it will take you with it.
     
  20. anonymous

    anonymous Guest

    So you got your wish Paige is gone . Now do your job, maybe we made a serious mistake in your hire . Feel free to return your sign on bonus on the way out the door.